Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

The last time I wrote about Rhythm Pharmaceuticals, Inc. (RYTM) it was in a Seeking Alpha article entitled "Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't The Only Catalyst On Deck." In this ...

Merck and Eisai's experimental combination ​treatments for a type of ‌kidney cancer failed to meet the main goals of a ...

April 16 (Reuters) - Roche on Thursday said it is initiating a late stage study for its gene therapy Elevidys following ...

A calm late night study session sharing real moments of focus and productivity, with simple insights to help you stay ...

Viking Therapeutics climbs after it completes enrollment in the second phase III obesity study for VK2735 and advances its bid in a fast-growing, competitive weight-loss market.

SANTA BARBARA, Calif. (KEYT) – Starting Sep. 25, the UCSB Library will end Late Night Study at 1 a.m. The library will be closed between 1 a.m. and 8 a.m. There won't be 24-hour access like there used ...